Humana ( (HUM) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Humana shares are climbing as investors cheer the company’s strong Q1 2026 earnings beat, reaffirmed guidance, and a brighter Medicare Advantage rate outlook for 2027. The stock is also gaining from signs that medical costs are stabilizing across the sector, as highlighted by both Humana and rival UnitedHealth.
Analyst sentiment is turning more bullish, with several firms lifting their targets on the stock. Notably, Bernstein raised its price target to $288, signaling growing institutional confidence in Humana’s long‑term margin recovery story and future profitability.
More about Humana
YTD Price Performance: -3.03%
Average Trading Volume: 1,912,936
Technical Sentiment Signal: Sell
Current Market Cap: $29.67B
For further insights into HUM stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.